Head of Investor Relations
Karyopharm Therapeutics Inc. (KPTI)Head of Investor Relations
Codexis, Inc. (CDXS)Equibles does not estimate personal net worth.
Get an email with a short summary when Karyopharm Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get KPTI alertsBrendan Strong is recorded as Head of Investor Relations at Karyopharm Therapeutics Inc. (KPTI) and Head of Investor Relations at Codexis, Inc. (CDXS). Brendan Strong has spoken on 8 earnings calls and 1 other investor event across 2 companies, most recently for Karyopharm Therapeutics Inc. on August 13, 2026. Those appearances were for Karyopharm Therapeutics Inc. (KPTI) and Codexis, Inc. (CDXS). Karyopharm Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Codexis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Karyopharm Therapeutics Inc. includes Richard Paulson (CEO and Board Member), Senior Clinical (CEO), Michael Mano (General Counsel) and 7 others.
“Good morning, and thank you all for joining us on today's conference call to discuss Cario Farm's second quarter 2026 financial results and recent company progress.”
“Good afternoon, everyone, and thank you all for joining us on today's conference call to discuss the phase three century trial of selenexer plus ruxolitinib in patients with myelofibrosis that was presented by Dr. John Mascarenas in a late-breaking oral presentation at ASCO this morning.”
“Good morning, and thank you all for joining us on today's conference call to discuss Cario Farms' first quarter 2026 financial results and recent company progress.”
“Good morning, and thank you all for joining us on today's conference call to discuss Carrier Farms' fourth quarter and full year 2025 financial results and recent company progress.”
“Good morning, and thank you all for joining us on today's conference call to discuss Karyopharm's third quarter 2025 financial results and recent company progress.”
Biotechnology · Healthcare
Head of Investor Relations
CDXS
Biotechnology · Healthcare
Head of Investor Relations
